W6 Flashcards

1
Q

what does CCNA stand for?

A

Canadian Consortium on Neurodegeneration in Aging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the aim of the CCNA?

A

national initiative aimed at tackling the growing onset of dementia and related illnesses and improving the lives of Canadians with illnesses and families and caregivers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

who was the Minister of Health that launched the CCNA?

A

Rona Ambrose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the 3 themes for research?

A
  • delaying onset
  • prevention
  • improve QOL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what was the general aim of CCNA?

A

combine expertise from across Canada and multiple disciplines
- broaden understanding of how NDD develop and the impact
- determine how to prevent, delay, modify progression and cope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the 4 objectives of CCNA?

A
  • strengthen and synergize research
  • become Canadian hub for leading and participating in international research
  • reinforce international positioning, competitiveness and impact of Canadian research at global level
  • improve QOL and quality of services
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the 4 categories that are integrated?

A
  • research
  • synergy
  • talent
  • inclusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the orientation to prevention?

A

primary
secondary
tertiary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is primary prevention?

A

protect healthy individuals from developing NDD
- risk assessment
- education about PFs
- risk reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is secondary prevention?

A

stop or delay the progress of NDD after risk classification or early diagnosis
- risk control and management
- monitor disease progress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is tertiary prevention?

A

manage disease progress -> co-morbidities that may exacerbate rate of disease progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what was phase1 of CCNA?

A

funding from multiple sources

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what was participant flow in COMPASS-ND?

A
  • recruitment into CCNA
  • informed consent signed
  • history, physical, cognitive eval
  • questionnaires
  • psychometric testing
  • biosamples - blood, saliva, CSF
  • sample processing
  • sample shipping to biobank
  • mri imaging acquistion
  • mri it and databasing
  • brain donation program and follow-up in clinic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the 6 goals of CCNA phase 2?

A
  • understanding subgroups
  • develop or test new treatment molecules
  • develop prevention strategies
  • allow earlier diagnosis
  • innovate life improvements
  • optimize health care delivery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the platforms associated with CCNA?

A

neuroimaging
can-thumbs up
Loris
COMPASS-ND

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how many teams are there for CCNA?

A

19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are the cross-cutting programs?

A
  • knowledge translation and exchange
  • training and capacity building
  • women, sex, gender, dementia
  • ethical, legal and social implications
  • engagement of people with lived experience
  • indigenous cog health
  • social inclusion and stigma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is the NDD diagnoses approach 1?

A

focus on “pure” cases of each (strict inclusion and exclusion criteria)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is the narrow focus on approach 1?

A

craft diagnostic criteria to produce homogenous groups that represent a fraction of dementia population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is the purity involved with approach 1?

A

exclude co-morbidities and mixed dementias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what was NDD diagnosis approach 2?

A

broader choice of inclusion and exclusion criteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is the inclusivity of approach 2?

A

broadly inclusive will produce heterogenous groups that will cover entire dementia population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what is the ecological representation of approach 2?

A

includes almost all co-morbidities and mixed

24
Q

what is the rationale behind approach 2?

A

difficult to specify criteria and detect pure disease cases

25
what is the limitation to approach 2?
heterogeneity within diagnostic groups
26
what is NDD diagnosis approach 3?
moderate application of inclusion and exclusion criteria
27
what is the compromise with approach 3?
"rather broad" criteria: produce less homogenous groups that represent most of dementia pop
28
who is represented in approach 3?
co-morbidities and mixed dementias
29
are all mixed diseases included in approach 3?
no only most
30
who will be excluded from approach 3?
brain disease major psychiatric disturbance drug addiction
31
what model did Kaarin Ansety create?
CHELM
32
what does CHELM stand for?
cognitive health environment lifecourse model
33
what approach is close to CHELM?
CLASS
34
why is the CHELM approach similar to CLASS?
- core ideas in brain/cog aging and dementia - importance of longitudinal approaches - adding multi-modal RF to DPM
35
what is the overlap and relatedness between CHELM and CLASS?
differential changes, intra-individual, mechanisms, plasticity cascades of risk (broader focus)
36
what are the 2 types of reserve capacity?
brain: passive, cognition affected after accumulation of pathology cognitive: active, cognition continues despite brain pathology
37
what is the chain for the CHELM model?
biomarkers to RF -> controllable RF -> modifiable RF -> bio-clinical outcomes -> prism of neurocognitive resources -> cognitive or clinical outcomes
38
what is the Lancet Commission?
comprehensive review - life course projection
39
how many modifiable RFs are there?
12 - education - hearing loss - hypertension - obesity - alcohol/tbi - smoking - depression - physical inactivity - social isolation - diabetes - air pollution
40
what are the 3 identified mechanisms of ND risk?
- reduction in brain/cognitive reserve/resilience - increasing brain damage as a fxn of disease and insult - spreading brain inflammation
41
what is the goal of the Lancet?
aim for reducing specific RF in order to modify risk mechanisms
42
what is Anstey's "umbrella review"?
systematic review of world-wide evidence on RFs of dementia
43
what are the 3 conclusions from Anstey's review?
- evidence base varies by NDD - lack of "early" effect evidence - much variability in geographical representation of evidence
44
what is the IRNDP?
international research network on dementia prevention - how systematic and diverse studies of RA can contribute to understanding differential pathways toward or away from ADRD
45
who founded IRNDP?
Anstey
46
what is the purpose of the risk assessment?
allows for early detection of risk and for application to RCTs and RR protocol
47
what are the 6 health factors contributing to vascular risk for unhealthy brain aging and dementia?
stroke obesity smoking high cholesterol hypertension diabetes
48
what are the 4 points from CULTURAL?
- need for cross-national and cultural investigations - need for linking RFs with associated mechanisms - need for harmonization - exploring new research targetsw
49
what is the summary of CULTURAL?
scientific, ethical, and practical imperative to expand dementia risk and prevention research across nations, cultures, regions and under-represented populations
50
what are the 4 directions for the IRNDP research?
- expand diversity research - expand attention to life course exposure variations - expand evidence base - expand long-term follow-up research
51
what are some social determinants of health affecting degree of or access to potential RF change?
- income and social status - education and literacy - employment and working conditions - early childhood development - physical environment and housing - social supports - access to health services - biology and genetics - gender - culture - race - disability and ableism
52
what is the principle of SSDH?
person's social and structural "context" affects RF, RR, possibilities for modifying risk or protection
53
what are SSDH?
non-medical, social, and economic factors that occur within everyday and working conditions of people and substantially influence the extent and direction of dementia risk
54
what are the challenges of SSDH?
modifiable RF and PF do not operate uniformly or universally, but only within the SSDH context of individuals
55
what is the implication of SSDH?
effectiveness of interventions to modify RFs and PFs depend on SSDH context
56
what are the communities of dementia and dementia risk?
- indigenous - growing # of older Ind and impacts of social determinants of health - racialized - ethnic profile of older people is growing - sex and gender - chronological age - early onset poses a challenge
57
what is the Tom Kitwood quote?
when you've met one person with dementia, you've met one person with dementia